A lawsuit was filed on behalf of investors in Roka Bioscience Inc (NASDAQ:ROKA) shares over alleged securities laws violations. Deadline: February 23, 2015. NASDAQ:ROKA investors should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 12/30/2014 -- An investor, who purchased shares of Roka Bioscience Inc (NASDAQ:ROKA), filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Roka Bioscience in connection with certain allegedly false and misleading statements made between July 17, 2014 and November 6, 2014.
Investors who purchased shares of Roka Bioscience Inc (NASDAQ:ROKA) between July 17, 2014 and November 6, 2014, have certain options and for certain investors are short and strict deadlines running. Deadline: February 23, 2015. NASDAQ:ROKA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint the plaintiff alleges on behalf of purchasers of Roka Bioscience Inc (NASDAQ:ROKA) common shares between July 17, 2014 and November 6, 2014, that the defendants violated Federal Securities Laws.
More specifically, the plaintiff claims that Roka Bioscience Inc 's initial public offering ("IPO") documents allegedly failed to disclose known trends and uncertainties about the drastic decline in demand for its Atlas instruments that existed at the time of the IPO.
Roka Bioscience Inc reported that its annual Total Revenue rose from $0.10 million in 2012 to $2.18 million in 2013. Roka Bioscience Inc went public in July 2014 at $12 per share.
On November 6, 2014 Roka Bioscience Inc reported its third quarter 2014 financial results. Roka Bioscience reports a Net Loss for the third quarter was $9.1 million, or a loss of $(0.64) per share, compared with $9.4 million, or a loss of $(17.00) per share, for the same period in 2013. Additionally, Roka Bioscience Inc reported that there were no new Atlas® instruments placements made during the quarter. Shares of Roka Bioscience Inc (NASDAQ:ROKA) declined to as low as $2.97 per share on November 7, 2014.
On December 31, 2014, NASDAQ:ROKA shares closed at $4.41 per share.
Those who purchased shares of Roka Bioscience Inc (NASDAQ:ROKA) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com